Eric Wenzler

37PUBLICATIONS
26CO-AUTHORS
Medical bacteriologyMedical virologyCancer therapy (excl. chemotherapy and radiation therapy)Infectious agentsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (37)

|Apr 16, 2024
Amoxicillin-Clavulanate Breakpoints Against Enterobacterales: Rationale for Revision by the Clinical and Laboratory Standards Institute.

Navaneeth Narayanan, Amy J Mathers, Eric Wenzler

|Feb 24, 2023
Antimicrobial susceptibility testing: An updated primer for clinicians in the era of antimicrobial resistance: Insights from the Society of Infectious Diseases Pharmacists.

Eric Wenzler, Mira Maximos, Tomefa E Asempa

|Aug 24, 2022
Breaking Down the Breakpoints: Rationale for the 2022 Clinical and Laboratory Standards Institute Revised Piperacillin-Tazobactam Breakpoints Against Enterobacterales.

Pranita D Tamma, Patrick N A Harris, Amy J Mathers

|Jul 21, 2022
Activity of Delafloxacin and Levofloxacin against Stenotrophomonas maltophilia at Simulated Plasma and Intrapulmonary pH Values.

Alesia Vialichka, Mark Biagi, Kevin Meyer

|Jun 01, 2022
Activity of Omadacycline Alone and in Combination against Carbapenem-Nonsusceptible Acinetobacter baumannii with Varying Minocycline Susceptibility.

Taylor Abbey, Alesia Vialichka, Michele Jurkovic

|May 28, 2022
Use of Novel Antibiograms to Determine the Need for Earlier Susceptibility Testing and Administration for New β-Lactam/β-Lactamase Inhibitors in the United States.

Kenneth P Klinker, Levita K Hidayat, Eric Wenzler

Pageof 7

Frequent Collaborators

4 joint publications

Zackery P Bulman

3 joint publications

Kristen L Bunnell

3 joint publications

Rodrigo E Mendes

2 joint publications

Christian G Giske